Viewing Study NCT01097369


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-01-01 @ 8:42 PM
Study NCT ID: NCT01097369
Status: TERMINATED
Last Update Posted: 2013-01-31
First Post: 2010-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elitek (Rasburicase) Immuno-Monitoring Study
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module